| Primary |
| Hepatitis C |
80.7% |
| Product Used For Unknown Indication |
5.4% |
| Chronic Hepatitis C |
4.5% |
| Diabetes Mellitus |
1.7% |
| Hypertension |
1.1% |
| Depression |
0.9% |
| Hiv Infection |
0.9% |
| Anaemia |
0.8% |
| Prophylaxis |
0.6% |
| Pruritus |
0.5% |
| Drug Dependence |
0.4% |
| Oedema |
0.4% |
| Pain |
0.4% |
| Cardiac Failure |
0.3% |
| Hypothyroidism |
0.3% |
| Ascites |
0.2% |
| Hepatic Steatosis |
0.2% |
| Osteoporosis |
0.2% |
| Urinary Tract Infection |
0.2% |
| Anxiety |
0.2% |
|
| Rash |
33.7% |
| Anaemia |
11.6% |
| Vomiting |
6.2% |
| Fatigue |
4.7% |
| Nausea |
4.3% |
| Thrombocytopenia |
4.3% |
| Pyrexia |
3.6% |
| Weight Decreased |
3.3% |
| Pruritus |
2.9% |
| Skin Reaction |
2.9% |
| Urticaria |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Rash Generalised |
2.5% |
| Rash Pruritic |
2.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.2% |
| Proctalgia |
2.2% |
| Dermatitis Exfoliative |
1.8% |
| Malaise |
1.8% |
| Neutropenia |
1.8% |
| Off Label Use |
1.8% |
|
| Secondary |
| Hepatitis C |
68.6% |
| Chronic Hepatitis C |
15.6% |
| Product Used For Unknown Indication |
4.5% |
| Hypertension |
2.3% |
| Prophylaxis |
1.5% |
| Hiv Infection |
0.9% |
| Diabetes Mellitus |
0.8% |
| Depression |
0.7% |
| Hepatic Cirrhosis |
0.6% |
| Pain |
0.6% |
| Rash |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
| Anaemia |
0.4% |
| Pruritus |
0.4% |
| Hepatitis C Virus Test Positive |
0.4% |
| Insomnia |
0.3% |
| Nausea |
0.3% |
| Pyrexia |
0.3% |
| Anxiety |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
|
| Rash |
16.9% |
| Vomiting |
12.6% |
| Weight Decreased |
8.2% |
| White Blood Cell Count Decreased |
8.2% |
| Anaemia |
7.3% |
| Nausea |
5.4% |
| Pyrexia |
5.2% |
| Thrombocytopenia |
4.8% |
| Pruritus |
4.7% |
| Drug Ineffective |
3.3% |
| Renal Impairment |
2.9% |
| Suicidal Ideation |
2.6% |
| Syncope |
2.5% |
| Rectal Haemorrhage |
2.4% |
| Transfusion |
2.4% |
| Pancytopenia |
2.3% |
| Tremor |
2.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.1% |
| Malaise |
2.1% |
| Decreased Appetite |
2.0% |
|
| Concomitant |
| Hepatitis C |
76.9% |
| Product Used For Unknown Indication |
4.5% |
| Hiv Infection |
2.5% |
| Chronic Hepatitis C |
2.4% |
| Prophylaxis |
2.0% |
| Hypertension |
1.7% |
| Depression |
1.3% |
| Anaemia |
1.2% |
| Insomnia |
1.1% |
| Nausea |
0.9% |
| Blood Potassium Decreased |
0.8% |
| Diabetes Mellitus |
0.8% |
| Hyperuricaemia |
0.8% |
| Constipation |
0.7% |
| Rheumatoid Arthritis |
0.5% |
| Rhinitis Allergic |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.4% |
| Inflammation |
0.4% |
| Osteoporosis |
0.4% |
| Anxiety |
0.3% |
|
| Rash |
16.4% |
| Vomiting |
12.7% |
| White Blood Cell Count Decreased |
8.2% |
| Weight Decreased |
6.7% |
| Pain |
6.0% |
| Pruritus |
5.2% |
| Drug Ineffective |
4.5% |
| Death |
3.7% |
| Pyrexia |
3.7% |
| Renal Failure |
3.7% |
| Somnolence |
3.7% |
| Anaemia |
3.0% |
| Injection Site Erythema |
3.0% |
| Nausea |
3.0% |
| No Therapeutic Response |
3.0% |
| Pyelonephritis Acute |
3.0% |
| Visual Impairment |
3.0% |
| Weight Increased |
3.0% |
| Haemorrhoids |
2.2% |
| Hepatitis C |
2.2% |
|
| Interacting |
| Chronic Hepatitis C |
27.0% |
| Hepatitis C |
23.0% |
| Product Used For Unknown Indication |
17.6% |
| Hypertension |
9.5% |
| Pulmonary Arterial Hypertension |
5.4% |
| Liver Transplant |
4.1% |
| Antiretroviral Therapy |
2.7% |
| Convulsion |
2.7% |
| Pain |
2.7% |
| Rash |
2.7% |
| Rash Macular |
2.7% |
|
| Renal Impairment |
30.4% |
| Drug Interaction |
26.1% |
| Confusional State |
8.7% |
| Thrombocytopenia |
8.7% |
| Drug Level Increased |
4.3% |
| Hepatitis C |
4.3% |
| Immunosuppressant Drug Level Increased |
4.3% |
| Malaise |
4.3% |
| Proctalgia |
4.3% |
| Weight Decreased |
4.3% |
|
